President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to helm the Department of Health and Human Services(HHS) is reportedly rattling drugmakers in light of Kennedy’s prior calls to ban pharmaceutical advertising.
If confirmed by the Senate to serve as HHS secretary, Kennedy could marshal the country’s public health agencies to implement his Make America Healthy Again (MAHA) priorities, leading one pharmaceutical industry observer to claim that Kennedy is likely to attempt a ban on direct-to-consumer (DTC) drug advertising. However, any attempt from Kennedy to crack down on pharmaceutical advertising would almost certainly be challenged by drugmakers on First Amendment grounds and may lack the support of Trump and Republican lawmakers who have so far refrained from commenting on Kennedy’s proposal.
“One of the things I’m going to advise Donald Trump to do in order to correct the chronic disease epidemic is to ban pharmaceutical advertising on TV,” Kennedy said to thunderous applause during a Tucker Carlson Live Tour event in Glendale, Arizona, on Oct. 31. “There’s only two countries in the world that allow pharmaceutical advertising on the airwaves. One of them is New Zealand and the other is us and we have the highest disease rate, and we buy more drugs and they’re more expensive than anywhere in the world.”
They banned cigarette advertising…because it was targeted at a vulnerable population…children!
Well Pharma ads are targeted at a vulnerable population…citizens that are NOT MDs and lack the education, training, certification, and experience to prescribe properly…
Maybe Big Parm should only be allowed to advertise that a consumer can get OTC.
They should not be allowed to advertise drugs that are by prescription.
Big Parm does not care about the consumer, their only in it for the money. Big Parm only wants to make money for themselves and their investors. Here is an example of what I would call price gouging
According to recent studies, the actual cost to manufacture a month’s supply of Ozempic is estimated to be less than $5, with some estimates placing it between 89 cents and $4.73, including a profit margin and taxes; however, the listed price for a month’s supply in the U.S. is close to $1,000 before insurance.
The medicine in an EpiPen is worth only about $1, and it costs only about $8 to manufacture a two-pack.
Brand name: A brand name EpiPen or EpiPen JR package, which contains two auto-injectors, can cost between $650 and $730.
Generic: A generic EpiPen can cost between $320 and $750.
ALL Big Parm companies should be investigated for price gouging !!!!!